Survey of risk factors of lithium-ION batteries used in ends
Ended Awarded Last action
- Contract number
- 75F40121F19010
- Awardee
-
Research Triangle Institute UEI JJHCMK4NT5N3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $475,954
Award facts
- Contract value 100% obligated
- $475,953.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Calverton, MD 20705, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$3,044 | |
| Terminate for Convenience | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $478,997 |
About this award
The Food and Drug Administration awarded a $475,953.50 firm fixed-price BPA call to Research Triangle Institute (doing business as RTI International) on July 22, 2021, for a survey of risk factors associated with lithium-ion batteries used in electronic nicotine delivery systems (ENDS). The contract, with an ultimate completion date of April 8, 2025, is being performed in Calverton, Maryland. This award falls under RTI's existing $70 million FDA Blanket Purchase Agreement for Quick Turnaround Social Science Research Services, which enables the agency to rapidly procure evidence synthesis and policy evaluation support through December 2030. The contract carries no set-aside designation, reflecting RTI's competitive standing as a nonprofit research organization with extensive experience delivering FDA-funded tobacco and nicotine-related research initiatives.
Survey Sampling International, LLC was engaged as a subcontractor on April 7, 2022, to provide technical assistance in survey sampling and statistical analysis capabilities. As a specialized provider of sampling methodology and statistical support services, Survey Sampling International's involvement underscores the survey-centric nature of this risk assessment project. RTI International's multidisciplinary research capabilities and established relationships with the FDA, combined with Survey Sampling International's technical expertise, position this effort to deliver evidence-based analysis on lithium-ion battery safety considerations relevant to the agency's regulatory oversight of ENDS products.
Quick answers
Who was awarded contract 75F40121F19010?
75F40121F19010 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on July 22, 2021.
How much is contract 75F40121F19010 worth?
The government has obligated $475,954 on 75F40121F19010.
Is contract 75F40121F19010 an order under another contract?
Yes. 75F40121F19010 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).
Was contract 75F40121F19010 competed?
The extent of competition for 75F40121F19010 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award